The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Monsanto's revenues will wither -0.7% and EPS will remain in the red.
The average estimate for revenue is $2.23 billion. On the bottom line, the average EPS estimate is -$0.43.
Last quarter, Monsanto reported revenue of $4.22 billion. GAAP reported sales were 17% higher than the prior-year quarter's $3.61 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.63. GAAP EPS of $1.74 for Q3 were 36% higher than the prior-year quarter's $1.28 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 56.0%, 130 basis points better than the prior-year quarter. Operating margin was 32.0%, 370 basis points better than the prior-year quarter. Net margin was 22.2%, 300 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $13.66 billion. The average EPS estimate is $3.72.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 2,849 members out of 2,979 rating the stock outperform, and 130 members rating it underperform. Among 584 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 560 give Monsanto a green thumbs-up, and 24 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Monsanto is outperform, with an average price target of $87.68.
- Add Monsanto to My Watchlist.